Trials / Unknown
UnknownNCT02843906
Cognitive, Morphological and Neurobiological Progressive Aspects in Bipolar Disorders in the Elderly: Toward to a Neurodegenerescence Detection?
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 180 (estimated)
- Sponsor
- University Hospital, Grenoble · Academic / Other
- Sex
- All
- Age
- 60 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to identify association between cerebrospinal fluid Alzheimer's Disease's neurodegenerescence biomarkers (tau, ptau, Aß40 and Aß1-42) and occurrence of cognitive deficits in older patients with bipolar disorders.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Lombar Punction | cerebrospinal fluid testing at screening and M36 |
| RADIATION | Magnetic Resonance Imaging (MRI) | MRI done at screening and M36 |
| RADIATION | Positron-Emission Tomography (TEP) /(FDG) | TEP/FDG done at screening and M36 |
| OTHER | Psychiatric tests | |
| OTHER | Neuropsychological Tests | done at screening, M12, M24 and M36 |
| GENETIC | Apolipoprotein (ApoE) detection | ApoE detection done at screening |
Timeline
- Start date
- 2015-07-01
- Primary completion
- 2018-07-01
- Completion
- 2018-07-01
- First posted
- 2016-07-26
- Last updated
- 2016-07-26
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT02843906. Inclusion in this directory is not an endorsement.